 |
|
|
| |
Sustained Viral Response and Safety of Vaniprevir (MK-7009) in Cirrhotic, Treatment-Experienced Patients with Genotype 1 HCV Infection Who Have Failed Previous Pegylated Interferon and Ribavirin
|
| |
| |
Reported by Jules Levin
The 48th Annual Meeting of the European Association for Study of The Liver
Amsterdam, The Netherlands, April 24-28, 2013
Maribel Rodriguez-Torres, Albrecht Stoehr, Edward Gane, Lawrence Serfaty, Eric Lawitz, Michael Bourque, Sanhita Bhanja, Richard Barnard, Peggy Hwang, Niloufar Mobashery
|
| |
|
|
|
|
|
